GGrantIndex
Sort

50,496 grants matching lung cancer

University of Maryland, Baltimore Biomarker Reference Laboratory

$491,976
Sanford A Stass · University Of Maryland Baltimore · U24 · FY2013 · CA

Radiomics of NSCLC

$491,968
Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2018 · CA

Rexinoid Synergy in Prostate Cancer Apoptosis

$491,829
Marcia I. Dawson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2007 · CA

Multiscale Nanotechnologies for Comprehensive Assessment of Lung Cancer in Blood

$491,768
Shan X. Wang · Stanford University · U54 · FY2017 · CA

Radiomics of NSCLC

$491,757
Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2013 · CA

Pathways of PAH activation in human lung cells

$491,748
Trevor M. Penning · University Of Pennsylvania · R01 · FY2009 · ES

5500 QTrap Mass Spectrometer for Yale University, Keck Laboratory

$491,747
Christopher Michael Colangelo · Yale University · S10 · FY2010 · RR

Predictors of Adult Leukemia

$491,742
Julie Ann Ross · University Of Minnesota · R01 · FY2009 · CA

Targeting DNA repair in KRAS mutated lung cancer by chemical screening

$491,730
You-Wei Zhang · Case Western Reserve University · R01 · FY2020 · CA

Defining the Pathogenesis and Prognosis of Human Acute Interstitial Nephritis

$491,708
Lloyd G Cantley · Yale University · R01 · FY2023 · DK

Developing a pharmacologic approach to treat LKB1 mutant NSCLC patients

$491,665
Adam I Marcus · Emory University · R01 · FY2019 · CA

Translating Molecular and Clinical Data to Population Lung Cancer Risk Assessment

$491,638
Rayjean J. Hung · Baylor College Of Medicine · U19 · FY2019 · CA

Master in Clinical Research

$491,600
Rosanne Carol Harrigan · University Of Hawaii At Manoa · R25 · FY2007 · RR

Targeting bidirectional signaling in lung stroma and cancer cells

$491,590
Uwe Rix · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2019 · CA

Targeted Inhibition in Leukemia

$491,521
Nicolas Nassar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · CA

Targeted Inhibition in Leukemia

$491,521
Nicolas Nassar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · CA

Contrast Agents for Far Red and Near Infrared Imaging

$491,492
Pti Research, Inc. · R44 · FY2001 · CA

Development of Risk and Early Detection Biomarker for Small Cell Lung Cancer

$491,462
Samir M Hanash · University Of Tx Md Anderson Can Ctr · U01 · FY2019 · CA

Biological Response to Air Quality Change in Beijing pre-, mid- and post-Olympics

$491,323
Lina Mu · State University Of New York At Buffalo · R01 · FY2011 · ES

Radiomics of NSCLC

$491,302
Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2014 · CA

Novel DNA damage response therapeutics targeting replication protein A

$491,249
John J Turchi · Indiana University Indianapolis · R01 · FY2025 · CA

Electrochemical Paper-Based Analytical Devices for Metal Determination

$491,244
Daniel D Miller-Lionberg · Access Sensor Technologies, Llc · R44 · FY2017 · ES

Targeted Treatment of Recurrent Small Cell Lung Cancer with Anti-AbnV2 Antibodies

$491,150
Roy H.l. Pang · Woomera Therapeutics, Inc. · R44 · FY2012 · CA

Pdcd4-Rictor Interaction in Suppression of Lung Tumorigenesis

$491,149
Hsin-Sheng Yang · University Of Kentucky · R01 · FY2023 · CA

Identification of a novel targetable cancer stem cell regulator promoting cancer progression and metastasis in non-small cell lung cancer

$491,137
Hui-Kuan Lin · Duke University · R01 · FY2024 · CA